BRWA
HAE icon

B. Riley Wealth Advisors’s Haemonetics HAE Stock Holding History

B. Riley Wealth Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-453
Closed -$17 – 1161
2014
Q4 		$17 Buy
+453
New +$16.6K ﹤0.01% 2629
2014
Q3 		– Sell
-453
Closed -$16K – 1166
2014
Q2 		$16K Buy
+453
New +$15.1K ﹤0.01% 1566

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

B. Riley Wealth Advisors's HAE Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Haemonetics (HAE) in Q1 2015, closing a stake of 453 shares — an estimated $17 sold.

B. Riley Wealth Advisors first reported a position in HAE in Q2 2014 and held it in 2 quarters. The position peaked at $16K in Q2 2014. 169 funds tracked by Wall St. Rank hold HAE as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining Haemonetics position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 453 Haemonetics shares in Q1 2015, an estimated $17.
  • B. Riley Wealth Advisors first reported a position in Haemonetics in Q2 2014 and held it in 2 quarters.
  • B. Riley Wealth Advisors's Haemonetics position peaked at $16K in Q2 2014.
  • 169 funds tracked by Wall St. Rank held Haemonetics as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.